[go: up one dir, main page]

CN104341430B - A kind of soil Radix Glycyrrhizae A and extracting method thereof and purposes - Google Patents

A kind of soil Radix Glycyrrhizae A and extracting method thereof and purposes Download PDF

Info

Publication number
CN104341430B
CN104341430B CN201410522224.9A CN201410522224A CN104341430B CN 104341430 B CN104341430 B CN 104341430B CN 201410522224 A CN201410522224 A CN 201410522224A CN 104341430 B CN104341430 B CN 104341430B
Authority
CN
China
Prior art keywords
extract
licorice
soil
cancer cells
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410522224.9A
Other languages
Chinese (zh)
Other versions
CN104341430A (en
Inventor
韦建华
霍丽妮
黄茂春
陈睿
冯旭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Huanuoxinde Technology Co Ltd
Original Assignee
Guangxi University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University of Chinese Medicine filed Critical Guangxi University of Chinese Medicine
Priority to CN201410522224.9A priority Critical patent/CN104341430B/en
Publication of CN104341430A publication Critical patent/CN104341430A/en
Application granted granted Critical
Publication of CN104341430B publication Critical patent/CN104341430B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种土甘草A及其提取方法和用途。该土甘草A的结构式为:该土甘草A的化学名称为3‑(对甲氧苯基)‑4‑羟基‑5‑甲氧基‑2’,2’‑二甲基‑6,7‑二氢吡喃香豆素,分子式为C22H20O6,相对分子量为380。本发明的土甘草A具有抗肿瘤等生物活性,并且其提取方法简便易行,提取率较高,能有效应用到制备抗肿瘤药物中,且能对人胃癌细胞、肝癌细胞株、人肺癌细胞、子宫颈癌细胞、卵巢癌细胞等产生很强抑制作用。The invention discloses a soil licorice A and its extraction method and application. The structural formula of the soil licorice A is: The chemical name of this licorice A is 3-(p-methoxyphenyl)-4-hydroxy-5-methoxy-2', 2'-dimethyl-6, 7-dihydropyranocoumarin, The molecular formula is C 22 H 20 O 6 , and the relative molecular weight is 380. The soil licorice A of the present invention has biological activities such as anti-tumor, and its extraction method is simple and easy, and the extraction rate is high, which can be effectively applied to the preparation of anti-tumor drugs, and can effectively treat human gastric cancer cells, liver cancer cell lines, and human lung cancer cells. , cervical cancer cells, ovarian cancer cells, etc. have a strong inhibitory effect.

Description

一种土甘草A及其提取方法和用途A kind of soil licorice A and its extraction method and application

技术领域technical field

本发明涉及医药化学技术领域,具体涉及一种土甘草A及其提取方法,以及将土甘草A用于制备抗肿瘤药物上。The invention relates to the technical field of medicinal chemistry, in particular to a soil licorice A and an extraction method thereof, and the use of soil licorice A to prepare antitumor drugs.

背景技术Background technique

癌症已上升为仅次于心血管疾病的人类第二大“杀手”疾病。癌症和心血管疾病已经成为死亡的首要原因。从植物中寻找开发有效抗肿瘤新药的前景是广阔的,目前,众多不同结构和作用机制的天然活性产物已成为国内外抗肿瘤新药研究的热点。在我国连续启动的两批重大新药创制项目中,植物来源药物特别是利用我国植物资源的天然药物的研发都被列为重点支持对象,由于植物来源的抗肿瘤药物的作用机制独特,抗癌疗效显著,已在临床应用上逐步占据主导地位。Cancer has risen to become the second largest "killer" disease of human beings after cardiovascular disease. Cancer and cardiovascular disease have become the leading causes of death. The prospect of finding and developing effective new anti-tumor drugs from plants is broad. At present, many natural active products with different structures and mechanisms of action have become a hot spot in the research of new anti-tumor drugs at home and abroad. Among the two batches of major new drug development projects launched continuously in my country, the research and development of plant-derived drugs, especially natural drugs using plant resources in my country, has been listed as key support objects. Due to the unique mechanism of action of plant-derived anti-tumor drugs, the anti-cancer efficacy Significantly, it has gradually occupied a dominant position in clinical application.

根据《中国植物志》记载,黄檀属植物(Dalbergia)在我国有28种,目前只有两种被研究,尤其是降香Dalbergia odorifera被研究得最多。许多药理活性均表明降香具有抗糖尿病,抗氧化,抗高血糖,抗炎,肿瘤以及抗菌等作用,因此从该属植物中开发出糖尿病药物非常有意义。两粤黄檀(Dalbergia benthami Prain),又名:蕉藤麻,两粤檀,藤本,生于疏林和灌木丛中,分布在广东、广西、海南等地。药用部位为茎,可用于通经活血,主治跌打损伤、筋骨疼痛和气滞血瘀所致月经不调等症状。According to the records of "Flora of China", there are 28 species of Dalbergia plants (Dalbergia) in my country, and only two species have been studied at present, especially Dalbergia odorifera has been studied the most. Many pharmacological activities have shown that balsamic has anti-diabetic, anti-oxidant, anti-hyperglycemic, anti-inflammatory, tumor and antibacterial effects, so it is very meaningful to develop diabetes drugs from this genus. Dalbergia benthami Prain, also known as: banana vine hemp, Liangyue sandalwood, vines, grows in sparse forests and bushes, and is distributed in Guangdong, Guangxi, Hainan and other places. The medicinal part is the stem, which can be used to promote menstruation and activate blood circulation, and mainly treat symptoms such as bruises, muscle and bone pain, and irregular menstruation caused by qi stagnation and blood stasis.

目前,对该植物的研究无任何文献报道.。本发明首次从该植物中分离出并鉴定出一化合物,经核磁、质谱鉴定为土甘草A,在植物中的含量高达3.5%。该化合物最初来源于土甘草Derris eriocarpa How中,但是该植物中含量较低,使得应用受到局限。土甘草A属于香豆素类化合物,具有抗肿瘤等生物活性,因此,本专利为该化合物的开发应用提供了有力的保证。At present, there is no literature report on the study of this plant. The present invention isolates and identifies a compound from the plant for the first time, which is identified as the soil licorice A by NMR and mass spectrometry, and the content in the plant is as high as 3.5%. The compound was originally derived from Derris eriocarpa How, but the content in this plant is low, which limits its application. Soil licorice A belongs to the coumarin compound, which has anti-tumor and other biological activities. Therefore, this patent provides a strong guarantee for the development and application of this compound.

发明内容Contents of the invention

本发明的一个目的是提供一种土甘草A,该土甘草A具有抗肿瘤等生物活性。另一个目的是提供一种提取该土甘草A的方法,并且该土甘草A能够应用在制备抗肿瘤药物中,使提取得的抗肿瘤药物具备有效的预防和抑制肿瘤恶化的作用。One object of the present invention is to provide a soil licorice A, which has biological activities such as antitumor. Another purpose is to provide a method for extracting the licorice root A, and the licorice root A can be used in the preparation of anti-tumor drugs, so that the extracted anti-tumor drugs can effectively prevent and inhibit tumor progression.

为了解决上述技术问题,本发明提供了一种土甘草A及其提取方法和用途。In order to solve the above technical problems, the present invention provides licorice root A and its extraction method and use.

本发明的土甘草A的结构式为:The structural formula of Soil Glycyrrhizae A of the present invention is:

该土甘草A的化学名称为:3-(对甲氧苯基)-4-羟基-5-甲氧基-2’,2’-二甲基-6,7-二氢吡喃香豆素;The chemical name of this licorice A is: 3-(p-methoxyphenyl)-4-hydroxyl-5-methoxy-2',2'-dimethyl-6,7-dihydropyranocoumarin ;

该土甘草A的分子式为:C22H20O6The molecular formula of the soil licorice A is: C 22 H2 0 O 6 ;

该土甘草A的相对分子量为:380。The relative molecular weight of the soil licorice A is: 380.

通过以下方法可以提取到该土甘草A,其包括如下步骤:Can be extracted to this licorice root A by following method, it comprises the steps:

1)以两粤黄檀粗粉为原料,以乙醇作为溶剂,采用渗漉法进行提取,蒸发溶剂后得到提取物浸膏。1) The coarse powder of Dalbergia japonica is used as a raw material, and ethanol is used as a solvent, and the percolation method is used for extraction, and the extract extract is obtained after evaporating the solvent.

2)将提取物浸膏加水悬浮,然后向悬浮液加入石油醚萃取并分离石油醚部位浸膏,再向悬浮液中加入乙酸乙酯萃取得到乙酸乙酯部位浸膏;2) add water to suspend the extract extract, then add petroleum ether to the suspension to extract and separate the extract from petroleum ether, then add ethyl acetate to the suspension to extract to obtain the extract from ethyl acetate;

3)取所述乙酸乙酯部位浸膏,反复用硅胶柱色谱分离,得到无色透明颗粒状结晶化合物,即为目标产物土甘草A。3) Take the extract from the ethyl acetate part, and repeatedly separate it by silica gel column chromatography to obtain a colorless and transparent granular crystalline compound, which is the target product, Licorice Root A.

该土甘草A可以用于制备抗肿瘤药物,比如制成抗肿瘤的注射剂、片剂、丸剂、胶囊、悬浮剂或乳剂中的一种或多种药品。The licorice root A can be used to prepare antitumor drugs, for example, to prepare one or more drugs in antitumor injections, tablets, pills, capsules, suspensions or emulsions.

本发明的有益效果:本发明从两粤黄檀中提取到的土甘草A具有抗肿瘤等生物活性。并且本发明的提取方法简便易行,提取率较高,能有效应用到制备抗肿瘤药物中,且能对人胃癌细胞、肝癌细胞株、人肺癌细胞、子宫颈癌细胞、卵巢癌细胞等产生很强抑制作用。Beneficial effects of the present invention: the soil licorice A extracted from Dalbergia japonica in the present invention has biological activities such as anti-tumor. Moreover, the extraction method of the present invention is simple and easy to implement, has a high extraction rate, can be effectively applied to the preparation of antineoplastic drugs, and can be effective against human gastric cancer cells, liver cancer cell lines, human lung cancer cells, cervical cancer cells, ovarian cancer cells, etc. Strong inhibitory effect.

具体实施方式detailed description

下面结合实施例对本发明做进一步的详细说明,以令本领域技术人员参照说明书文字能够据以实施。The present invention will be further described in detail below in conjunction with the embodiments, so that those skilled in the art can implement it with reference to the description.

实施例1Example 1

本发明土甘草A的提取方法包括如下具体步骤:The extraction method of soil licorice A of the present invention comprises following specific steps:

1)取两粤黄檀粗粉10.0kg,用10倍量80%乙醇渗漉提取,合并提取液,蒸发溶剂后得到提取物浸膏;1) Take 10.0kg of the coarse powder of Dalbergia japonica, extract by percolation with 10 times the amount of 80% ethanol, combine the extracts, and evaporate the solvent to obtain the extract extract;

2)将提取物浸膏加水悬浮,然后向悬浮液加入石油醚萃取并分离石油醚部位浸膏,再向悬浮液中加入乙酸乙酯萃取得到乙酸乙酯部位浸膏;2) add water to suspend the extract extract, then add petroleum ether to the suspension to extract and separate the extract from petroleum ether, then add ethyl acetate to the suspension to extract to obtain the extract from ethyl acetate;

3)取乙酸乙酯部位浸膏30g,反复用硅胶柱色谱分离,得到无色透明颗粒状结晶化合物,即为目标产物土甘草A。该硅胶柱色谱分离的做法可以根据以下操作:先以氯仿-丙酮梯度洗脱(氯仿→80∶1→50∶1→30∶1→151→7∶1→3∶1→丙酮),共收集358流份,用TLC检识合并,合并相同流分,共得到14个组分(A、B、C、D、E、F、G、H、I、G、K、L、M、N);其中,I组分为白色粉末状,然后取300mg组分I,以石油醚-丙酮梯度洗脱(15∶1→7∶1→3∶1),共收集103流份,用TLC检识合并,合并相同流分,得到的组分在石油醚-丙酮(7∶1)洗脱部位,得到无色透明颗粒状结晶化合物80.55mg,该无色透明颗粒状结晶化合物为土甘草A。3) Take 30 g of the extract from the part of ethyl acetate, and repeatedly separate it by silica gel column chromatography to obtain a colorless and transparent granular crystalline compound, which is the target product Glycyrrhizae A. The way of this silica gel column chromatographic separation can be according to following operation: first with chloroform-acetone gradient elution (chloroform → 80: 1 → 50: 1 → 30: 1 → 15 : 1 → 7: 1 → 3: 1 → acetone), A total of 358 fractions were collected, combined with TLC detection, and the same fractions were combined to obtain 14 components (A, B, C, D, E, F, G, H, I, G, K, L, M, N); wherein, component I is a white powder, then take 300mg component I, and elute with petroleum ether-acetone gradient (15:1 → 7:1 → 3:1), collect 103 fractions altogether, use TLC The detection and identification were combined, and the same fractions were combined. The obtained components were eluted in petroleum ether-acetone (7:1), and 80.55 mg of a colorless and transparent granular crystalline compound was obtained. The colorless and transparent granular crystalline compound was Glycyrrhizae A .

上述实施例1提取得的土甘草A的结构式为:The structural formula of the Radix Glycyrrhizae A that above-mentioned embodiment 1 extracts is:

该土甘草A的化学名称为3-(对甲氧苯基)-4-羟基-5-甲氧基-2’,2’-二甲基-6,7-二氢吡喃香豆素,分子式为C22H20O6,相对分子量为380。经过理化分析仪得到其理化性质为:无色透明颗粒状,m.p.203-206℃。EI-MS(m/z):381[M+1]+,380[M]+,315[M-15],337,321,307,233,232,217,203,175,161,148,138,133。1H-NMR(400MHz,CDCl3)δ:9.97(1H,s,4-OH),7.46(2H,dd,J=11.4Hz,2.9Hz,H-2′,H-6′),6.97(2H,dd,J=8.7Hz,2.9Hz,H-3′,H-5′),6.63(1H,s,H-Ar),6.50(1H,d,J=10Hz,H-4″),5.77(1H,d,J=10Hz,H-3″),3.96(3H,s,4′-OCH3),3.77(3H,s,5-OCH3),1.48(6H,s,-CH3)。13C-NMR(125MHz,CDCl3)δ:160.1(C-2),101.7(C-3),162.6(C-4),153.7(C-5),124.2(C-6),157.6(C-7),110.6(C-8),152.1(C-9),103.8(C-10),123.2(C-1′),131.4(C-2′),113.5(C-3′),158.8(C-4′),113.5(C-5′),131.4(C-6′),77.5(C-2″),115.0(C-3″),131.7(C-4″),64.4(3′-OCH3),55.2(5-OCH3)。The chemical name of this licorice A is 3-(p-methoxyphenyl)-4-hydroxy-5-methoxy-2',2'-dimethyl-6,7-dihydropyranocoumarin, The molecular formula is C 22 H 20 O 6 , and the relative molecular weight is 380. The physical and chemical properties obtained by the physical and chemical analyzer are: colorless transparent granular, mp203-206 °C. EI-MS(m/z): 381[M+1] + , 380[M] + , 315[M-15], 337, 321, 307, 233, 232, 217, 203, 175, 161, 148, 138, 133. 1 H-NMR (400MHz, CDCl 3 ) δ: 9.97 (1H, s, 4-OH), 7.46 (2H, dd, J=11.4Hz, 2.9Hz, H-2′, H-6′), 6.97( 2H, dd, J=8.7Hz, 2.9Hz, H-3′, H-5′), 6.63 (1H, s, H-Ar), 6.50 (1H, d, J=10Hz, H-4″), 5.77 (1H, d, J=10Hz, H-3″), 3.96 (3H, s, 4′-OCH 3 ), 3.77 (3H, s, 5-OCH 3 ), 1.48 (6H, s, -CH 3 ). 13 C-NMR (125MHz, CDCl 3 ) δ: 160.1 (C-2), 101.7 (C-3), 162.6 (C-4), 153.7 (C-5), 124.2 (C-6), 157.6 (C -7), 110.6(C-8), 152.1(C-9), 103.8(C-10), 123.2(C-1′), 131.4(C-2′), 113.5(C-3′), 158.8 (C-4'), 113.5(C-5'), 131.4(C-6'), 77.5(C-2"), 115.0(C-3"), 131.7(C-4"), 64.4(3 '-OCH 3 ), 55.2 (5-OCH 3 ).

实施例2Example 2

将上述实施例1提取得到的土甘草A进行体外抗肿瘤活性实验:The soil licorice A that is extracted from the above-mentioned embodiment 1 is carried out in vitro anti-tumor activity experiment:

MTT法广泛用于一些生物活性因子的活性检测、大规模的抗肿瘤药物筛选、细胞毒性试验以及肿瘤放射敏感性测定等,具有灵敏度高、经济等特点。外源性MTT能被活细胞线粒体中的琥珀酸脱氢酶还原为水不溶性的蓝紫色结晶甲瓒(Formazan)并沉积在细胞中,用酶联免疫检测仪在490nm波长处测定其光吸收值,可间接反映活细胞数量。在一定细胞数范围内,MTT结晶形成的量与细胞数成正比。通过计算化合物对肿瘤细胞抑制率为50%时,所对应药物的浓度,称为半数抑制浓度IC50,即半数抑制浓度,一般来说,IC50的数值越小,说明该药物对细胞的抑制活性越高。本实验利用Bliss法计算得到了本发明的土甘草A和5-FU对人胃癌细胞、肝癌细胞株、人肺癌细胞、子宫颈癌细胞、卵巢癌细胞等抑制率为50%时的IC50值。实验结果如下表所示:MTT method is widely used in the activity detection of some biologically active factors, large-scale antitumor drug screening, cytotoxicity test and tumor radiosensitivity determination, etc. It has the characteristics of high sensitivity and economy. Exogenous MTT can be reduced to water-insoluble blue-purple crystalline formazan (Formazan) by succinate dehydrogenase in the mitochondria of living cells and deposited in the cells, and its light absorption value is measured at a wavelength of 490nm by an enzyme-linked immunosorbent assay , which can indirectly reflect the number of living cells. Within a certain cell number range, the amount of MTT crystal formation is proportional to the cell number. By calculating the concentration of the corresponding drug when the inhibitory rate of the compound on tumor cells is 50%, it is called the half inhibitory concentration IC 50 , that is, the half inhibitory concentration. Generally speaking, the smaller the value of IC 50 , it indicates that the drug inhibits the cells. The higher the activity. In this experiment, the Bliss method was used to calculate the IC 50 value of licorice A and 5-FU of the present invention on human gastric cancer cells, liver cancer cell lines, human lung cancer cells, cervical cancer cells, ovarian cancer cells, etc. when the inhibition rate was 50%. . The experimental results are shown in the table below:

从实施例2的结果可以看出,本发明的土甘草A经体外抗肿瘤实验表明,其具有强的抗肿瘤活性成分。本发明的土甘草A可以制成抗肿瘤的注射剂、片剂、丸剂、胶囊、悬浮剂或乳剂中的一种或多种药品。本发明的土甘草A及其提取成的药物都能对人胃癌细胞、肝癌细胞株、人肺癌细胞、子宫颈癌细胞、卵巢癌细胞等产生很强抑制作用。从表中的对比数据可得,其对子宫颈癌细胞HeLa的抑制作用最为明显,治疗效果更好,并且本发明的土甘草A对其他癌细胞的抑制作用也比5-FU的效果要好,本发明为研究开发新的抗肿瘤药物提供了新的思路。From the results of Example 2, it can be seen that the soil licorice A of the present invention has a strong anti-tumor active component through anti-tumor experiments in vitro. The licorice root A of the present invention can be made into one or more medicines in antitumor injections, tablets, pills, capsules, suspensions or emulsions. The licorice root A of the present invention and the medicine extracted therefrom can exert a strong inhibitory effect on human gastric cancer cells, liver cancer cell lines, human lung cancer cells, cervical cancer cells, ovarian cancer cells and the like. From the comparative data in the table, it can be seen that its inhibitory effect on cervical cancer cells HeLa is the most obvious, and its therapeutic effect is better, and the inhibitory effect of Glycyrrhizae A of the present invention on other cancer cells is also better than that of 5-FU. The invention provides a new idea for researching and developing new antitumor drugs.

尽管本发明的实施方案已公开如上,但其并不仅仅限于说明书和实施方式中所列运用,它完全可以被适用于各种适合本发明的领域,对于熟悉本领域的人员而言,可容易地实现另外的修改,因此在不背离权利要求及等同范围所限定的一般概念下,本发明并不限于特定的细节。Although the embodiment of the present invention has been disclosed as above, it is not limited to the use listed in the specification and implementation, it can be applied to various fields suitable for the present invention, and it can be easily understood by those skilled in the art Therefore, the invention is not limited to the specific details without departing from the general concept defined by the claims and their equivalents.

Claims (1)

1.一种土甘草A的提取方法,其特征在于,包括如下步骤提取:1. an extracting method of Glycyrrhizae A, is characterized in that, comprises the following steps to extract: 1)以两粤黄檀粗粉为原料,以乙醇作为溶剂,采用渗漉法进行提取,蒸发溶剂后得到提取物浸膏;1) using the coarse powder of Dalbergia japonica as a raw material, using ethanol as a solvent, extracting by percolation, and obtaining the extract extract after evaporating the solvent; 2)将所述提取物浸膏加水悬浮,然后向悬浮液加入石油醚萃取并分离石油醚部位浸膏,再向悬浮液中加入乙酸乙酯萃取得到乙酸乙酯部位浸膏;2) add water to suspend the extract extract, then add petroleum ether to the suspension to extract and separate the extract from petroleum ether, then add ethyl acetate to the suspension to extract to obtain the extract from ethyl acetate; 3)取所述乙酸乙酯部位浸膏,反复用硅胶柱色谱分离,得到无色透明颗粒状结晶化合物,即为目标产物土甘草A。3) Take the extract from the ethyl acetate part, and repeatedly separate it by silica gel column chromatography to obtain a colorless and transparent granular crystalline compound, which is the target product, Licorice Root A.
CN201410522224.9A 2014-09-30 2014-09-30 A kind of soil Radix Glycyrrhizae A and extracting method thereof and purposes Active CN104341430B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410522224.9A CN104341430B (en) 2014-09-30 2014-09-30 A kind of soil Radix Glycyrrhizae A and extracting method thereof and purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410522224.9A CN104341430B (en) 2014-09-30 2014-09-30 A kind of soil Radix Glycyrrhizae A and extracting method thereof and purposes

Publications (2)

Publication Number Publication Date
CN104341430A CN104341430A (en) 2015-02-11
CN104341430B true CN104341430B (en) 2016-08-24

Family

ID=52497954

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410522224.9A Active CN104341430B (en) 2014-09-30 2014-09-30 A kind of soil Radix Glycyrrhizae A and extracting method thereof and purposes

Country Status (1)

Country Link
CN (1) CN104341430B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104945408B (en) * 2015-04-30 2017-07-11 广西民族大学 Coumarin kind compound and its preparation method and application
CN105287692A (en) * 2015-11-25 2016-02-03 广西中医药大学 Dalbergia benthami prain extractive, and preparation method and application thereof
CN105287511B (en) * 2015-11-25 2018-07-10 广西中医药大学 The application of native Radix Glycyrrhizae A
CN107033115B (en) * 2017-03-14 2019-02-15 广西中医药大学 Liangyue Dalbergia ketone and its extraction method
CN109232599B (en) * 2018-10-08 2021-04-20 广西中医药大学 O-p-trifluoromethyl benzoyl soil licorice A with antitumor activity and its prepn and use
CN109232601A (en) * 2018-10-08 2019-01-18 广西中医药大学 With active native Radix Glycyrrhizae A derivative of anti-cervical cancer and its preparation method and application
CN109232600B (en) * 2018-10-08 2021-04-20 广西中医药大学 O-p-methylbenzyl licorice A with antitumor activity, preparation method, pharmaceutical preparation and use
CN111217825B (en) * 2020-02-25 2022-09-20 广西大学 4-O-Aminopropyl licorice A derivative and its preparation and application
CN111217824B (en) * 2020-02-25 2022-09-23 广西大学 4-O-Arylaminopropyl licorice A derivative and its preparation and application
CN112655758B (en) * 2020-12-30 2024-02-27 广西壮族自治区药用植物园 Application of radix glycyrrhizae extract in preparation of fruit and vegetable preservative
CN115197236B (en) * 2022-06-29 2023-09-19 广西中医药大学 Linear type glabra A analogue and preparation and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010042728A1 (en) * 2008-10-08 2010-04-15 Cornell University Small molecule modulators of prongf uptake

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010042728A1 (en) * 2008-10-08 2010-04-15 Cornell University Small molecule modulators of prongf uptake

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Flavonoids and stilbenoids from Derris eriocarpa";Hong-Xia Zhang et al.;《Fitoterapia》;20140329;第95卷;第147-153页 *
"异叶三宝木叶的化学成分研究";唐贵华 等;《天然产物研究与开发》;20131231;第25卷;第912-915页 *

Also Published As

Publication number Publication date
CN104341430A (en) 2015-02-11

Similar Documents

Publication Publication Date Title
CN104341430B (en) A kind of soil Radix Glycyrrhizae A and extracting method thereof and purposes
CN101824067A (en) Barrigenol-type triterpenoid saponins compound, preparation method and application thereof
CN103316096A (en) General flavone extract of seeds of nigella damascena l., nigella sativa l. or nigella glandulifera freyn et sint., and preparation method and use thereof
CN115215881A (en) Guaifenesin-type sesquiterpenoids prepared from Persimmon tangutere and their preparation method and application
CN105037464B (en) A kind of setose thistle flavone compound and preparation method thereof and the application in antitumor or liver-protecting medicine is prepared
CN109232491A (en) The Preparation method and use of benzofuran compounds in a kind of Herba Serissae
CN102000066B (en) Inula helianthus-aquatica extract, anti-tumor medicament using same as active ingredient, preparation method and application thereof
CN102516213B (en) Sesquiterpene compound and preparation method and application thereof
CN102304158A (en) Acylated flavonoid glycoside compounds and application thereof in preparation of complement inhibitor medicines
CN106580937B (en) The preparation method of euphorbia ebiacteolata Hayata element A and its preparing the application in breast cancer medicines
CN110194754B (en) Ligularia fischeri fat-soluble extract and preparation method and application thereof
CN103610682B (en) The preparation method of 3 Alpha-hydroxy-30-olive-12,20 (29)-diene-28-acid and preparing the application in antitumor drug
CN106749124B (en) O-ditetrahydrofuran-type custard lactone compounds with antitumor activity and preparation method and application thereof
CN101514143A (en) Method for preparing ginkgol
CN105079011A (en) Preparation and application of anti-tumor medicament
CN103800308B (en) Cycloartane type falls triterpene and is preparing the purposes in antitumor drug
CN106349021B (en) A compound in auspicious grass and its preparation and application
CN106588614B (en) A kind of preparation method and application of diphenylmethane compound
CN104116767B (en) A kind of preparation method of Alternanthera philoxeroides ligroin extraction and utilization
CN111470955B (en) Phenanthrene compound with anti-tumor effect, preparation method and application
CN118126050B (en) 6-Methoxy carbazole alkaloid compound and preparation method and application thereof
CN109705183A (en) Smelly seven secondary metabolites and pharmaceutical compositions thereof, preparation method and application thereof
CN105439878B (en) 1,3 indandione class compound screwtree root alkali and its medicinal usage
Wang et al. Study on the extraction of flavonoids from Artemisia integrifolia and its anti-lung cancer activity
CN102908381B (en) A kind of fresh Rhizoma Bolbostematis extract and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20200428

Address after: 314500 No.1 xc1001-3, Gongnong Road, Nanmen, Chongfu Town, Tongxiang City, Jiaxing City, Zhejiang Province

Patentee after: JIAXING YUNSHIJIAO ELECTRONIC COMMERCE Co.,Ltd.

Address before: 13 No. 530213 the Guangxi Zhuang Autonomous Region Nanning Qingxiu District five Avenue

Patentee before: Guangxi University of Chinese Medicine

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20200513

Address after: Room B411, floor 4, building 1, No. 14, Zhonghe street, Beijing Economic and Technological Development Zone, Daxing District, Beijing 100176

Patentee after: Beijing huanuoxinde Technology Co., Ltd

Address before: 314500 No.1 xc1001-3, Gongnong Road, Nanmen, Chongfu Town, Tongxiang City, Jiaxing City, Zhejiang Province

Patentee before: JIAXING YUNSHIJIAO ELECTRONIC COMMERCE Co.,Ltd.

TR01 Transfer of patent right